Gainers
- Bone Biologics BBLG shares increased by 10.3% to $2.78 during Wednesday's after-market session. Bone Biologics's trading volume hit 412.8K shares by close, accounting for 26.6% of its average volume over the last 100 days. The company's market cap stands at $28.7 million.
- Phathom Pharmaceuticals PHAT stock rose 10.23% to $19.07. The company's market cap stands at $603.4 million.
- Envista Holdings NVST stock increased by 4.35% to $46.0. This security traded at a volume of 94.2K shares come close, making up 7.3% of its average volume over the last 100 days. The market value of their outstanding shares is at $7.4 billion. As per the press release, Q4 earnings came out today.
- Mainz Biomed MYNZ stock increased by 4.22% to $13.58. The company's market cap stands at $186.5 million.
- Gracell Biotechnologies GRCL shares increased by 3.91% to $4.25. The market value of their outstanding shares is at $286.8 million.
- GBS GBS shares moved upwards by 3.72% to $0.88. The market value of their outstanding shares is at $13.0 million.
Losers
- Aeglea BioTherapeutics AGLE stock decreased by 16.6% to $3.22 during Wednesday's after-market session. The market value of their outstanding shares is at $158.8 million.
- Seagen SGEN stock fell 12.32% to $124.0. Today's trading volume for this security ended up closing at 57.1K shares, which is 6.3 percent of its average volume over the last 100 days. The company's market cap stands at $22.6 billion. As per the news, the Q4 earnings report came out today.
- CohBar CWBR shares fell 6.63% to $0.31. The company's market cap stands at $26.6 million.
- NovoCure NVCR shares decreased by 5.89% to $76.54. The company's market cap stands at $7.9 billion.
- CareDx CDNA shares declined by 4.74% to $43.46. At the close, CareDx's trading volume reached 165.0K shares. This is 24.2% of its average volume over the last 100 days. The company's market cap stands at $2.2 billion.
- Hoth Therapeutics HOTH shares declined by 4.47% to $0.58. The market value of their outstanding shares is at $13.9 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in